Soreno: Siobhan McCrudden, a Psoriasis
Moderate-to-severe psoriasis patients fare better using Raptiva over placebo treatments, according to results from Serono’s 24-week clinical study CLEAR (Clinical Experience Acquired with Raptiva).
Moderate-to-severe psoriasis patients fare better using Raptiva over placebo treatments, according to results from Serono’s 24-week clinical study CLEAR (Clinical Experience Acquired with Raptiva).